Open AccessDoxorubicin enhances 131 I-rituximab induced cell death in Raji cells
Author(s) -
Grace Samuel,
Chandan Kumar,
BN Pandey,
M. Venkatesh
Publication year - 2015
Publication title -
journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/0973-1482.140844
Subject(s) - raji cell , doxorubicin , apoptosis , rituximab , cancer research , programmed cell death , lymphoma , chemistry , microbiology and biotechnology , medicine , biology , chemotherapy , immunology , biochemistry
There are various therapeutic modalities of treatment for non-Hodgkin's lymphoma, but with certain limitations, hence, investigating the scope of combined therapeutic approach.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom